Page 11 - Managing Science Editor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Managing science editor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Managing Science Editor Today - Breaking & Trending Today

#AANAM - Ocrevus, Used Early in MS, Helps to Protect Nervous System

team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference.
Treating multiple sclerosis (MS) in its earlier stages with Ocrevus (ocrelizumab) can substantially lower disease activity and lessen damage to the nervous system, new research demonstrates.
“We are encouraged by these new analyses showing that early treatment with Ocrevus may significantly control disease progression in both relapsing-remitting MS and in primary progressive MS,” Levi Garraway, MD, PhD, chief medical officer and head of global product development at Genentech (a member of the Roche Group), which makes Ocrevus, said in a press release. ....

United States , New York , Levi Garraway , Timothy Vollmer , Gabriel Pardo , Robert Zivadinov , University Of Lisbon , Biomedical Sciences , Oklahoma Medical Research Foundation , University Of Colorado , Society Of America , University Of Pittsburgh , American Academy Of Neurology , Roche Group , University At Buffalo , Multiple Sclerosis News Todayteam , American Academy , Diagnosed Early Stage , Disability Progression , Serum Neurofilament , Year Interim Data From , Ocrelizumab Phase , Expanded Disability Status Scale , Cerebrospinal Fluid , Primary Progressive Multiple Sclerosis , Disease Modifying Therapies ,

#AANAM – Mavenclad, for RRMS, Lowers Long-term Need for Other DMTs

#AANAM – Mavenclad, for RRMS, Lowers Long-term Need for Other DMTs
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

United States , Long Beach , Gavin Giovannoni , Serono Merck Kga , University Of Bordeaux , University Of Lisbon , Steering Committee , American Academy Of Neurology , London School Of Medicine , Biomedical Sciences , Columbia University , Multiple Sclerosis News Todayteam , London School , American Academy , Long Term Efficacy , Real World Treatment Patterns , Relapsing Multiple Sclerosis , Received Cladribine Tablets , Expanded Disability Status Scale , Cladribine Tablets , Interim Analysis , Bruno Brochet , Molecular Biology , Universidade Nova De Lisboa , Managing Science Editor , ஒன்றுபட்டது மாநிலங்களில் ,

#AANAM - Ocrevus, Rituximab Linked to More Severe COVID-19 Cases

#AANAM - Ocrevus, Rituximab Linked to More Severe COVID-19 Cases
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

United States , Maria Pia Sormani , University Of Genoa , University Of Lisbon , University Of Pittsburgh , Society Of America , American Academy Of Neurology , Biomedical Sciences , Multiple Sclerosis News Todayteam , Multiple Sclerosis , American Academy , Molecular Pathology , Molecular Biology , Universidade Nova De Lisboa , Managing Science Editor , ஒன்றுபட்டது மாநிலங்களில் , பல்கலைக்கழகம் ஆஃப் ஜெனோவா , பல்கலைக்கழகம் ஆஃப் லிஸ்பன் , பல்கலைக்கழகம் ஆஃப் பிட்ஸ்பர்க் , சமூகம் ஆஃப் அமெரிக்கா , அமெரிக்கன் கலைக்கழகம் ஆஃப் நரம்பியல் , உயிர் மருத்துவ அறிவியல் , பல ஸ்க்லரோசிஸ் , அமெரிக்கன் கலைக்கழகம் , மூலக்கூறு நோயியல் , மூலக்கூறு உயிரியல் ,

Gilenya Increases Infection Risk in MS Patients, Clinical Data Suggest

Gilenya is an oral treatment from Novartis that’s approved for relapsing forms of MS in people ages 10 and older. It works by retaining immune cells in lymph nodes (immune-related structures) and preventing them from reaching the brain and spinal cord, where they could cause damage to the protective myelin sheath surrounding nerve fibers.
By reducing the number of immune cells in circulation, Gilenya may reduce the immune system’s ability to fight off infectious pathogens. Yet, whether Gilenya treatment is associated with a greater risk of infections compared with other MS treatments remains controversial.
To shed light on this, researchers in China reviewed data from published clinical trials that assessed Gilenya, against a placebo or other disease-modifying therapies (DMTs), in MS patients. ....

New York , United States , Columbia University , University Of Lisbon , Department Of Microbiology Immunology , Biomedical Sciences , Cochrane Library , Laboratory Of Doctor Davida Fidock , University Nova De Lisboa , Cell Biology , Doctor David , Molecular Biology , Universidade Nova De Lisboa , Managing Science Editor , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , கொலம்பியா பல்கலைக்கழகம் , பல்கலைக்கழகம் ஆஃப் லிஸ்பன் , துறை ஆஃப் நுண்ணுயிரியல் நோயெதிர்ப்பு , உயிர் மருத்துவ அறிவியல் , கோக்ரேன் நூலகம் , பல்கலைக்கழகம் நோவா டி லிஸ்போவா , செல் உயிரியல் , மருத்துவர் டேவிட் , மூலக்கூறு உயிரியல் , யுனிவர்சிடேட் நோவா டி லிஸ்போவா ,

#AANAM - More Diversity Needed Among Neurologists, Presenters Agree

team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference.
There is a lack of diversity among neurologists, who are disproportionately white men, but new programs aimed at inclusivity may help neurologists to better reflect the communities they serve.
Racial, ethnic, and gender disparities among neurologists, and strategies to address them, were discussed in several talks at this year’s virtual American Academy of Neurology Annual Meeting, which began April 17 and ends today.
Diversity among neurologists and other doctors is important for delivering optimal healthcare. Research has shown that increasing minority representation among healthcare providers can lead to better outcomes for minority patients, through factors like increased cultural competency (the ability to understand and interact with people of a particular cultural background), which is critical for bridging dispar ....

New York , United States , University Of Rochester , Fabiola Valenzuela , Robert Stone , University Of Lisbon , University Of Rochester Predoc Program , American Academy Of Neurology Annual Meeting , Biomedical Sciences , Weill Cornell Medical College , Society Of America , University Of Pittsburgh , Multiple Sclerosis News Todayteam , American Academy , Neurology Annual Meeting , Ethnic Diversity , Neurology Residents , Texas Rio Grande Valley School , African American , Pacific Islander , Alaskan Native , Clinical Undergraduate Pipeline Program , Engage Underrepresented Individuals , Rochester Predoc Program , Molecular Pathology , Molecular Biology ,